Literature DB >> 35582084

The efficacy of pacemaker implantation for extracardiac total cavopulmonary connection in a pediatric patient with bradycardia-tachycardia syndrome.

Shuhei Fujita1, Eriko Kabata1, Keigo Nishida1, Kazuyuki Ueno1, Takeshi Futatani1, Noboru Igarashi1, Akira Murata2, Kiyoshi Hatasaki1.   

Abstract

A 9-year-old boy, diagnosed with double outlet right ventricle after birth, suffered sinus node dysfunction and non-sustained junctional tachycardia after an extracardiac total cavopulmonary connection (TCPC). Spontaneous atrial tachycardia appeared 3 years after an extracardiac TCPC. Sotalol was administered but the bradycardia was obvious. It was difficult to increase sotalol and atrial tachycardia was uncontrollable. Atrial tachycardia continued with symptoms; direct current (DC) cardioversion was frequently required. Five years after extracardiac TCPC, we implanted a pacemaker with atrial antitachycardia pacing (ATP) using epicardial leads. On day 2 post operation, wide QRS tachycardia appeared. Due to decreased blood pressure, DC cardioversion was immediately performed, but it recurred from atrial premature contraction. We judged this was atrial tachycardia with 1:1 atrioventricular conduction based on an intracardiac electrogram and it was terminated by burst atrial pacing from the pacemaker. After changing atrial pacing rate to 150 ppm, atrial tachycardia could be suppressed. Due to atrial pacing and increasing sotalol gradually, junctional tachycardia terminated spontaneously, and atrial tachycardia was not induced after pacemaker implantation. In conclusion, implantation of a pacemaker with ATP and intensification of antiarrhythmic drugs is an effective treatment strategy for pediatric patients with bradycardia-tachycardia syndrome after extracardiac TCPC. <Learning objective: The treatment for bradycardia-tachycardia syndrome in children after extracardiac total cavopulmonary connection (TCPC) is challenging. The appropriate antiarrhythmic drugs for atrial tachycardia cannot be administered due to bradycardia, and it is often difficult to perform radiofrequency catheter ablation on small children. Surgical pacemaker implantation, although invasive, is the most effective treatment for bradycardia-tachycardia syndrome in small children after extracardiac TCPC.>.
© 2021 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Atrial antitachycardia pacing; Bradycardia-tachycardia syndrome; Extracardiac total cavopulmonary connection; Pacemaker; Sinus node dysfunction

Year:  2021        PMID: 35582084      PMCID: PMC9091513          DOI: 10.1016/j.jccase.2021.10.008

Source DB:  PubMed          Journal:  J Cardiol Cases        ISSN: 1878-5409


  10 in total

1.  Long term management of atrial arrhythmias in young patients with sick sinus syndrome undergoing early operation to correct congenital heart disease.

Authors:  Fabrizio Drago; Massimo Stefano Silvetti; Giorgia Grutter; Antonella De Santis
Journal:  Europace       Date:  2006-07       Impact factor: 5.214

2.  Influence of patient factors and ablative technologies on outcomes of radiofrequency ablation of intra-atrial re-entrant tachycardia in patients with congenital heart disease.

Authors:  John K Triedman; Mark E Alexander; Barry A Love; Kathryn K Collins; Charles I Berul; Laura M Bevilacqua; Edward P Walsh
Journal:  J Am Coll Cardiol       Date:  2002-06-05       Impact factor: 24.094

3.  Device management of arrhythmias after Fontan conversion.

Authors:  Sabrina Tsao; Barbara J Deal; Carl L Backer; Kendra Ward; Wayne H Franklin; Constantine Mavroudis
Journal:  J Thorac Cardiovasc Surg       Date:  2009-06-17       Impact factor: 5.209

4.  Antitachycardia pacemakers in congenital heart disease.

Authors:  Anna N Kamp; Martin J LaPage; Gerald A Serwer; Macdonald Dick; David J Bradley
Journal:  Congenit Heart Dis       Date:  2014-11-07       Impact factor: 2.007

5.  Evaluation and Management of the Child and Adult With Fontan Circulation: A Scientific Statement From the American Heart Association.

Authors:  Jack Rychik; Andrew M Atz; David S Celermajer; Barbara J Deal; Michael A Gatzoulis; Marc H Gewillig; Tain-Yen Hsia; Daphne T Hsu; Adrienne H Kovacs; Brian W McCrindle; Jane W Newburger; Nancy A Pike; Mark Rodefeld; David N Rosenthal; Kurt R Schumacher; Bradley S Marino; Karen Stout; Gruschen Veldtman; Adel K Younoszai; Yves d'Udekem
Journal:  Circulation       Date:  2019-07-01       Impact factor: 29.690

Review 6.  Supraventricular Tachycardia in Adult Congenital Heart Disease: Mechanisms, Diagnosis, and Clinical Aspects.

Authors:  Christopher M Janson; Maully J Shah
Journal:  Card Electrophysiol Clin       Date:  2017-06

7.  Efficacy and safety of sotalol for refractory tachyarrhythmias in congenital heart disease.

Authors:  Aya Miyazaki; Hideo Ohuchi; Ken-ichi Kurosaki; Shiro Kamakura; Toshikatsu Yagihara; Osamu Yamada
Journal:  Circ J       Date:  2008-10-17       Impact factor: 2.993

8.  Management of late atrial tachyarrhythmia long after Fontan operation.

Authors:  Shuhei Fujita; Kazuhiro Takahashi; Daiji Takeuchi; Tetsuyuki Manaka; Morio Shoda; Nobuhisa Hagiwara; Hiromi Kurosawa; Toshio Nakanishi
Journal:  J Cardiol       Date:  2009-03-09       Impact factor: 3.159

9.  Safety and efficacy of atrial antitachycardia pacing in congenital heart disease.

Authors:  Collin C Kramer; Jennifer R Maldonado; Mark D Olson; Jean C Gingerich; Luis A Ochoa; Ian H Law
Journal:  Heart Rhythm       Date:  2017-12-12       Impact factor: 6.343

10.  Extracardiac autologous pericardial tunnel Fontan allows implantation of an endocardial atrial lead for sinus node dysfunction.

Authors:  Jennifer Newcombe; Brent Gordon; Anees Razzouk; Leonard Bailey; Ravi Mandapati
Journal:  Ann Thorac Surg       Date:  2014-09       Impact factor: 4.330

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.